Prostate cancer: When to offer screening in the primary care setting

Geriatrics

Volumn 56, Issue 1, 2001, Pages 22-31

  Gambert, S R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR;

CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COST; HUMAN; MALE; MASS SCREENING; PHYSICAL EXAMINATION; PRIMARY MEDICAL CARE; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY;

AGED; HEALTH SERVICES FOR THE AGED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHYSICAL EXAMINATION; PRIMARY HEALTH CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0035161858     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Cancer statistics, 1999
2. Report on the 1992 Prostate Cancer Awareness Week
3. Prostate Cancer Awareness Week: Results of screening
4. Screening digital rectal examination and prostate cancer mortality: A population-based casecontrol study
5. Diagnosis and staging of prostate cancer
6. Screening for prostate cancer with high-resolution ultrasound
7. Screening for prostatic cancer with high-resolution ultrasound
8. The effect of digital rectal examination on prostate-specific antigen levels
9. Early detection of prostate cancer, part II: Estimating the risks, benefits, and costs
10. Screening for prostate cancer: A decision analytical view
11. A decision analysis of alternative treatment strategies for clinically localized prostate cancer
12. Prostate-specific antigen: The best prostatic tumor marker. The socioeconomic implications of prostate-specific antigen screening
13. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
14. Screening decreases prostate cancer death: First analysis of the 1988 Quebec prospective randomized controlled trial
15. Relationship of prostate-specific antigen levels to prostate volume and age in mass screening subjects
16. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination
17. Longitudinal screening for prostate cancer with prostate-specific antigen
18. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population
19. Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels